Cardiovascular · 2019

FDA-cleared AI devices for cardiovascular 2019

2019 has 15 cardiovascular AI devices, 50% more than 2018 (10). That is 9.7% of the 154 cardiovascular devices on the FDA list, and 18.8% of all AI-device decisions dated 2019. The most active were Biofourmis Singapore Pte. Ltd (2), AliveCor, Inc. (1), CathWorks Ltd (1). The newest is FFRangio from CathWorks Ltd, decided on December 9, 2019.

152019 devices
14Companies
18.8%Of all 2019 AI devices
9.7%Of all cardiovascular

By month

Jan: 1Feb: 1Mar: 3Apr: 1May: 1Jun: 0Jul: 1Aug: 3Sep: 1Oct: 0Nov: 2Dec: 1
JanFebMarAprMayJunJulAugSepOctNovDec
Cardiovascular AI devices by month in 2019: Jan 1, Feb 1, Mar 3, Apr 1, May 1, Jun 0, Jul 1, Aug 3, Sep 1, Oct 0, Nov 2, Dec 1

All 15 devices

Frequently asked questions

How many FDA-cleared AI cardiovascular devices were there in 2019?

15 AI-enabled cardiovascular devices have a final decision dated 2019, from 14 companies.

How does 2019 compare with 2018 for AI cardiovascular devices?

2019 has 15 cardiovascular AI devices, 50% more than 2018 (10).

Which companies cleared the most AI cardiovascular devices in 2019?

Biofourmis Singapore Pte. Ltd (2), AliveCor, Inc. (1), CathWorks Ltd (1).

What was the most recent AI cardiovascular device in 2019?

FFRangio from CathWorks Ltd (K192442), decided on December 9, 2019. Product code QEK.

Which product codes were most common for AI cardiovascular devices in 2019?

DQK (Computer, Diagnostic, Programmable): 3; DXH (Transmitters And Receivers, Electrocardiograph, Telephone): 2; DPS (Electrocardiograph): 1.

Cite as: AI Device Radar, “FDA-cleared AI devices for cardiovascular 2019,” https://ai-device-radar.vercel.app/specialty/cardiovascular/2019 (FDA list through 2026-06-29).